Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02818218 · ClinicalTrials.gov registry record
Superior Vena Cava and Its Relationship to Central Venous Pressure Measurements in Liver Transplantation
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 58
- Enrollment target
NCT02818218 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 58 participants.
The verdict
NCT02818218 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
Study Summary
Consecutive patients undergoing liver transplant surgery will be included in the study. Before surgical incision, during the preanhepatic phase, during the anhepatic phase, during the postanhepatic phase and following closure of the deep fascial layer of the anterior abdominal wall simultaneous measurement of SVC diameter, SBC collapsibility index and CVP will be recorded.
Interventions
- PROCEDURE Liver Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2020-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02818218
The ClinicalTrials.gov registry entry for NCT02818218 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Liver Transplant is the first listed.
NCT02818218 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02818218 about?
NCT02818218 is a clinical study titled "Superior Vena Cava and Its Relationship to Central Venous Pressure Measurements in Liver Transplantation". Consecutive patients undergoing liver transplant surgery will be included in the study. Before surgical incision, during the preanhepatic phase, during the anhepatic phase, during the postanhepatic phase and following closure of the deep fascial layer of the anterior abdominal wall simultaneous meas...
What is the current status of trial NCT02818218?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2016-07-01. Estimated completion is 2020-09.
What interventions are being tested in trial NCT02818218?
The interventions under investigation include: Liver Transplant (PROCEDURE).
Who is sponsoring clinical trial NCT02818218?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.